Mediaire
Mediaire is a Berlin-based medical-imaging AI company founded in 2018 that builds deep-learning software (mdbrain, mdprostate, mdknee, SwiftMR) for automated MRI analysis, deployed in 350+ European hospitals and radiology practices on a volume-based subscription model.
- Company typePrivate
- Founded2018
- HeadquartersBerlin, Germany
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Mediaire does
Mediaire GmbH is a Berlin-based medical imaging software company founded in 2018 that develops AI-powered diagnostic tools for magnetic resonance imaging (MRI). Its core platform, the md-suite, includes mdbrain (brain volumetry, lesion characterization, aneurysm detection and tumor differentiation), mdprostate (automated prostate MRI analysis with PI-RADS 2.1 classification), mdknee (knee MRI cartilage assessment per ICRS criteria), and SwiftMR. The products are built on proprietary deep-learning algorithms that automate segmentation, quantification, and reporting, and are integrated directly into the Picture Archiving and Communication Systems (PACS) used by hospitals and radiology practices.
The company sells to hospital radiology and neuroradiology departments, independent radiology practices, and imaging centers across Europe, with distribution both through direct enterprise sales and via PACS-vendor marketplaces such as the SECTRA AmplifierStore. Pricing is volume-based subscription billed monthly, with free trials available; the company emphasizes local data hosting for European data-residency compliance. As of November 2024 Mediaire reported deployment in over 350 hospitals and clinics with solutions covering approximately 24% of all MRIs across its installed base, and that monthly recurring revenue had tripled since Q1 2023.
The business is privately held and venture- and PE-backed, having raised approximately €12 million in a November 2024 round led by LBO France with participation from IBB Ventures, Wille Finance, HTGF, LIFTT, and Gateway Ventures. The company is led by CEO Dr. Andreas Lemke, with co-founder Jörg Döpfert as CTO. Recent strategic emphasis has been on expanding beyond neuro imaging into prostate and adjacent oncology workflows, evidenced by the 2024 launch of mdprostate and the March 2026 interoperability partnership with Mint Medical (an Snke OS company).
Mediaire firmographics
Firmographics- Name
- Mediaire
- Legal name
- mediaire GmbH
- Website
- https://mediaire.de
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Mediaire is a Berlin-based medical-imaging AI company founded in 2018 that builds deep-learning software (mdbrain, mdprostate, mdknee, SwiftMR) for automated MRI analysis, deployed in 350+ European hospitals and radiology practices on a volume-based subscription model.
- Ownership category
- akta.pro rank
Mediaire industry classification
Industry- Product category
- Radiology AI Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
- akta.pro secondary industries
- AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Imaging Informatics & Workflow (PACS/RIS/VNA) (HLAHABAI), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ)
Keywords
Where Mediaire is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Mediaire business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- MRI AI Diagnostic Software Subscriptions: Volume-based subscription model where healthcare providers pay according to usage volume for AI-powered MRI diagnostic tools. The company reports transparent and flexible pricing without hidden costs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Usage-based | Monthly | Volume-based subscription |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
Mediaire product offering
Product offeringCore offering
Mediaire develops and sells AI-powered software for MRI diagnostics, offering an integrated suite (md-suite) of tools that automate brain volumetry, lesion characterization, aneurysm detection, tumor differentiation, prostate MRI classification (PI-RADS 2.1), and knee MRI cartilage assessment (ICRS). The software integrates directly into radiology PACS workflows and generates automated reports with norm value comparisons, targeting radiologists at hospitals, clinics, and independent imaging centers.
Product overview
Mediaire offers md-suite, a unified AI-powered platform for MRI diagnostics covering brain, prostate, and knee imaging. The platform includes three main products: mdbrain (brain MRI analysis with modules for brain volumetry, lesion characterization, aneurysm detection, and tumor differentiation), mdprostate (prostate MRI evaluation with PI-RADS 2.1 classification), and mdknee (automated knee MRI analysis with ICRS cartilage classification). Products are integrated into existing PACS workflows and generate automated reports with norm value comparisons. The company also offers SwiftMR as part of its product portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- md-suite: AI-based software suite for MRI assessments covering brain, prostate, and knee diagnostics.
- mdbrain
- mdprostate
- mdknee
- SwiftMR
Products and services
- md-suite Comprehensive AI-based software suite for MRI assessments covering brain, prostate, and knee diagnostics, integrating into existing PACS workflows and producing automatically generated reports with norm value comparisons.
- mdbrain AI-based solution for quantitative neuro-imaging and brain MRI evaluation, providing automated brain volumetry, lesion characterization, aneurysm detection, and tumor differentiation for conditions including dementia, multiple sclerosis, gliomas, and metastases.
- mdprostate AI-powered solution for automated prostate MRI diagnosis, providing static and longitudinal evaluation with automatic lesion detection and classification according to the PI-RADS 2.1 standard.
- mdknee AI tool for automated analysis of knee MRIs, automatically classifying cartilage damage according to ICRS criteria with anatomical assignment, designed to handle repetitive assessment tasks in orthopedic radiology.
- SwiftMR AI-powered MRI solution listed in the mediaire product portfolio alongside the md-suite products; specific capabilities not detailed in available source material.
Quantifiable outcome
- Monthly recurring revenue tripled since Q1 2023
- +3 more outcomes
Companies that use Mediaire
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Mediaire technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
Mediaire partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Mint Medical (Snke company)coreCollaboration announced March 2026 to advance AI-powered MRI workflows through interoperability of Mint Medical's mint Lesion and Mediaire's mdprostate solutions. The partnership strengthens the prostate cancer care pathway by combining两家公司的AI技术优势。
- SECTRAcoremdbrain is available at SECTRA AmplifierStore, enabling Mediaire to make AI-based solutions available to SECTRA customers globally. The partnership leverages SECTRA's PACS ecosystem for broader market reach.
Scale indicators5 records
Recent moves5 records
Expansion highlights6 records
Mediaire competitors and assessment
Company assessmentDirect peers
- icometrix: icometrix develops AI solutions for brain MRI analysis (including MS and dementia quantification) — a direct overlap with Mediaire's mdbrain product in the same clinical use cases and customer base of hospital radiology departments.
- Cortechs.ai: Cortechs.ai markets NeuroQuant, the leading FDA-cleared brain volumetry product for MRI, directly competing with Mediaire's mdbrain brain volumetry module among neuroradiology practices and hospitals.
- Subtle Medical: Subtle Medical offers AI-powered MRI image enhancement and workflow tools (e.g., SubtleMR), serving the same radiology AI market for MRI diagnostics with adjacent use cases to Mediaire's md-suite.
- Quibim: Quibim provides AI-powered imaging biomarkers and radiology AI products with European roots; it competes with Mediaire in quantitative MRI analysis for hospital and research customers.
Broad incumbents
- Aidoc: Aidoc is a leading AI radiology platform covering multiple modalities and use cases across hospital systems; it competes with Mediaire in AI-driven diagnostic workflows and offers broader portfolio coverage.
- RapidAI: RapidAI provides AI for stroke, aneurysm, and other neurovascular imaging; it overlaps with Mediaire's aneurysm detection and brain tumor differentiation modules within hospital radiology.
- Viz.ai: Viz.ai is a leading AI care coordination and imaging analytics platform that competes broadly with Mediaire in hospital radiology AI workflows, particularly in neurovascular indications.
- Qure.ai: Qure.ai develops AI for imaging diagnostics across multiple modalities and geographies; it overlaps with Mediaire in radiology AI for hospitals, with broader modality coverage.
- Brainlab: Brainlab is a large imaging informatics and surgical software vendor serving hospital radiology and neurosurgery; it overlaps with Mediaire in MRI AI and PACS-adjacent workflows for hospitals.
Emerging players
- Tempus AI (Arterys): Tempus AI acquired Arterys, a pioneer in cloud-native MRI AI for cardiac and other imaging; it competes with Mediaire in MRI-focused radiology AI, now backed by Tempus's broader data and diagnostics platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mediaire social profiles
Digital presenceMediaire financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mediaire leadership team
Management profileNumber of profiles
Profiles3 records
Mediaire funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mediaire M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mediaire
What does Mediaire do?
Mediaire develops and sells AI-powered software for MRI diagnostics, offering an integrated suite (md-suite) of tools that automate brain volumetry, lesion characterization, aneurysm detection, tumor differentiation, prostate MRI classification (PI-RADS 2.1), and knee MRI cartilage assessment (ICRS). The software integrates directly into radiology PACS workflows and generates automated reports with norm value comparisons, targeting radiologists at hospitals, clinics, and independent imaging centers.
Is Mediaire a public or private company?
Mediaire is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mediaire founded?
Mediaire was founded in 2018. It employs 11 to 50 people.
Where is Mediaire based?
Mediaire is headquartered in Berlin, Germany, in the Europe region.
How does Mediaire make money?
One revenue line is on record: MRI AI Diagnostic Software Subscriptions.
Who are Mediaire's main competitors?
Direct peers on record are icometrix, Cortechs.ai, Subtle Medical and Quibim. Broad incumbents are Aidoc, RapidAI, Viz.ai, Qure.ai and Brainlab. Tempus AI (Arterys) is listed as an emerging player.
Does Mediaire have an API?
No public API is recorded for Mediaire.
What industry is Mediaire in?
Mediaire's product category is Radiology AI Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLACALAG, AI Orchestration & Imaging Analytics Platforms (Model Management/Triage). Its NAICS code is 513210 and its SIC code is 7372.